Shandong Wego Interventional Medical Technology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shandong Wego Interventional Medical Technology - overview
Established
1988
Location
Shenzhen, -, China
Primary Industry
Medical Devices & Equipment
About
Based in Shenzhen, China, and founded in 1988, WEGO Healthcare (Shenzhen) Co. , Ltd. operates as a medical device and pharmaceutical company that manufactures medical equipment used in neuro intervention, cardiovascular interventions, and peripheral vascular intervention procedures. In October 2021, WEGO Healthcare Co.
, Ltd. raised USD 155 million in a Series A funding led by Xinjin Investment, with participation from CCB International, China-Belgium Direct Equity Investment Fund, and Haitong-Fortis Private Equity Fund Management. The group (WEGO) employs more than 30,000 people across 90 owned subsidiaries and 10 business groups under WEGO. WEGO Healthcare (Shenzhen) Co.
, Ltd. provides healthcare products under three segments, which are cardiovascular interventions, neuro interventions and peripheral interventions. The company’s cardiovascular interventions product segment offers Atrial septal defect occluder, ventricular septal defect occluder, patent ductus artery occluder, Xinsorb® bioresorbable sirolimus-eluting scaffold, ablation catheter, and Helios® sirolimus-eluting coronary stent with biodegradable polymer technology for cardiac health. The company’s neuro intervention product segment offers a detachable coil and delivery system for intracranial aneurysm embolization and Envi™-SR retriever for mechanical thrombectomy.
The Peripheral Interventions product line offers an IIIicium® vena cava filter system and disposable blood pressure transducer. WEGO Healthcare Co. , Ltd. plans to use its proceeds from a series A funding for product development and market expansion.
Current Investors
CCB International, Haitong-Fortis Private Equity Fund Management, China-Belgium Direct Equity Investment Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.wego-intervention.com/
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.